Select Bibliography

Filter by any of these (after searching):

NCCTG-9741

AUTHOR ABSTRACT DEADLINES

A meeting abstract must be submitted by the first or corresponding author to the Alliance Publications Coordinator (publications@AllianceNCTN.org) at least two weeks prior to the meeting abstract submission deadline. For detailed information about Alliance Publications guidelines, please refer to the policies, along with the author abstract deadlines.

There are 3 items

Updated efficacy and toxicity analysis of irinotecan and oxaliplatin (IROX) : intergroup trial N9741 in first-line treatment of metastatic colorectal cancer.

Ashley, Amanda C , Sargent, Daniel J , Alberts, Steven R ... - - Cancer - 2007

Manuscript - Primary - Long-Term-Followup - GI - NCCTG-9741

Bayesian Variable Selection with Joint Modeling of Categorical and Survival Outcomes: An Application to Individualizing Chemotherapy Treatment in Advanced Colorectal Cancer

Chen, Wei , Ghosh, Debashis , Raghunathan, Trivellore E. ... - - Biometrics - 2009

Manuscript - Secondary-not-in-original - Primary - GI - NCCTG-9741

Predictive polygenic score for outcome after first-line oxaliplatin-based chemotherapy in colorectal cancer patients using supervised principal component analysis

Park, A. , Edelmann, Dominic , Canzian, Federico ... - ESHG - Cancer Epidemiol Biomarkers Prev - 2022

Abstract - Secondary-not-in-original - Primary - PPP - Alliance-A151904 , NCCTG-9741 , NCCTG-N0147